ALGN Stock Recent News

Align Technology's (ALGN) fourth-quarter 2023 results are likely to reflect the strength of the Clear Aligner and Systems & Services businesses.

Investors remain optimistic about Align Technology (ALGN) due to the progress in the Invisalign portfolio and highly favorable solvency.

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2023 financial results on Wednesday, January 31, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT.

Investors are optimistic about Align Technology (ALGN), driven by recent strategic alliance and geographic expansion.

Because the past few months in the stock market have been a wild emotional roller coaster, most investors are now looking for the most logical and fundamental reasons to justify investing in any sector. Today, new pieces of data are being blasted across your monitor, so it is alright to feel pulled in a thousand directions.

Align's (ALGN) Invisalign Palatal Expander is the company's first direct 3D-printed orthodontic device. It offers a safe, pleasant and clinically effective alternative to traditional palatal expanders.

Align Technologies' (ALGN) Invisalign Palatal Expander system receives an updated medical device license from Health Canada.

Align Technology (ALGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Investors are optimistic about Align Technology (ALGN) on global expansion and strategic alliance.

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?